Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery
- 9 October 2013
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 21 (3) , 173-184
Abstract
Novel LNCs (lipid nanocrystals) were developed with an aim to improve the solubility, stability and targeting efficiency of the model drug glibenclamide (GLB). PEG 20000, Tween 80 and soybean lecithin were used as polymer, surfactant and complexing agent, respectively. GLB nanocrystals (NCs) were prepared by precipitation process and complexed using hot and cold melt technique. The LNCs were evaluated by drug loading, saturation solubility (SL), optical clarity, in vitro dissolution, solid state characterization, in vivo and stability analysis. LNCs exhibited a threefold increase in SL and a higher dissolution rate than GLB. The percentage dissolution efficiency was found to decrease with increase in PEG 20000. The average particle size was in the range of 155–842 nm and zeta potential values tend to increase after complexation. X-ray powder diffractometry and differential scanning calorimetry results proved the crystallinity prevailed in the samples. Spherical shaped particles (In vivo study findings showed a decrease in drug concentration to pancreas in male Wistar rats. It can be concluded that LNCs are could offer enhanced solubility, dissolution rate and stability for poorly water soluble drugs. The targeting efficiency of LNCs was decreased and further membrane permeability studies ought to be carried out.Keywords
This publication has 25 references indexed in Scilit:
- Nimodipine nanocrystals for oral bioavailability improvement: Preparation, characterization and pharmacokinetic studiesColloids and Surfaces B: Biointerfaces, 2013
- Development and characterization of glimepiride nanocrystal formulation and evaluation of its pharmacokinetic in ratsDrug Delivery, 2012
- The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological SystemsAnnual Review of Biomedical Engineering, 2012
- Drug nanocrystals: In vivo performancesJournal of Controlled Release, 2012
- In situ controlled crystallization as a tool to improve the dissolution of GlibenclamideInternational Journal of Pharmaceutics, 2012
- Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolutionAdvanced Drug Delivery Reviews, 2012
- Nanonization strategies for poorly water-soluble drugsDrug Discovery Today, 2011
- Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering☆Advanced Drug Delivery Reviews, 2007
- Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targetingInternational Journal of Pharmaceutics, 2005
- Pharmacokinetic and pharmacodynamic studies of glibenclamide in non‐ insulin dependent diabetes mellitus.British Journal of Clinical Pharmacology, 1990